Sontuzumab

Sontuzumab (AS1402) is a humanised IgG1κ MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P99591
Product Details
HY-P99591

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
372075-37-1

Menu

Settings